BioAegis Therapeutics and EastHORN Expand Phase 2 COVID-19 Clinical Trial within Spain and into Romania
BioAegis’ Phase 2 clinical trial of recombinant human plasma...
Patients Receive New Potential Treatment for Severe Pneumonia Associated with COVID-19
August 11, 2020 ___________________________________________...
EastHORN’s response to the coronavirus Covid-19 crisis
Our priorities at this challenging time are the well-being o...
Pavla Nevolová – Country Head, EastHORN Czech Republic – recent interview in Pharma Boardroom
Pavla Nevolová, country head of EastHORN in the Czech Republ...
EastHORN joining the global fight against Coronavirus
At EastHORN, a European CRO, we are joining the global fight...
Covid-19 Pandemic
The Covid-19 pandemic is now upon us in Europe and we want t...
3rd-4th March 2020 – Outsourcing in Clinical Trials West Coast, San Francisco Airport, Burlingame, CA
EastHORN will be present at OCT West Coast in San Francisco,...
Happy Winter Holidays!
We are so proud of our children's work, that we just have to...
Happy Winter Holidays!
We are so proud of our children's work, that we just have to...
9th-10th October 2019 – Outsourcing in Clinical Trials DACH, Munich
EastHORN will be present at OCT DACH in Munich, on 9th-10th...
24th- 25th September 2019 – Outsourcing in Clinical Trials Southern California 2019
We're happy to let you know that we are going to be present...
23rd – 27th June – DIA Annual Meeting, 2019
EastHORN is pleased to announce its participation at this ye...